Dr. Fuqian Xie is currently the cofounder of Shanghai BioCasting Pharmaceutical Co. Ltd since 2017, a start-up featured 3D cell culture, organoid and organ-on-chip technology in the application of disease modeling, drug discovery, toxicology and nutrition. He completed his B.E. in polymer material at Zhejiang University, China, and PhD degree in biophysics at University of Missouri – St. Louis,USA, then he received his postdoc training at Washington University in St. Louis School of Medicine, USA. His research covered multidisciplinary areas such as microfluidics, single molecule spectroscopy, protein engineering and 3D cell imaging. He joined Chinese biopharmaceuticals to lead a few biosimilar and innovation drug discovery programs towards IND filing before cofounding BioCasting Pharmaceuticals. He was selected in Beijing S&T Nova Program 2016-2018 and also received startup grant funded by Chinese Ministry of Human Resources and Society Security.